Biodexa Pharmaceuticals Plc (BDRX): BDRX...$1.22...🥳..Breaking 50MA...

Next 10 Prev Next

Send PM Follow Ignore

Followers	2369
Posts	118288
Boards Moderated	0
Alias Born	12/17/2011

georgie18

Re: georgie18 post# 318

Thursday, 04/02/2026 9:52:46 AM

Thursday, April 02, 2026 9:52:46 AM

BDRX...$1.22...🥳..Breaking 50MA to the Upside...

georgie18

Member Level
Re: georgie18 post# 719020

Thursday, April 02, 2026 9:41:44 AM

Post#
719022
of 719022
BDRX...$1.10...🥳...Off the .60 Bottom...

georgie18

Member Level
Re: georgie18 post# 404205

Thursday, April 02, 2026 9:34:00 AM

Post#
404604
of 404605
BDRX...92...🥳...Off the .60 Range Bottom... https://finviz.com/news/342131/biodexa-announces-partnership-with-syngene-to-manufacture-mtx240-gmp-clinical-trial-supplies

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent BDRX News

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/14/2026 08:00:10 PM
Biodexa issues letter to Shareholders • GlobeNewswire Inc. • 05/14/2026 12:30:00 PM
Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 04/02/2026 08:28:29 PM
Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 04/02/2026 08:28:29 PM
Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 04/02/2026 08:28:28 PM
Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 04/02/2026 08:28:28 PM
Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 04/02/2026 08:28:27 PM
Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 04/02/2026 08:28:27 PM
Biodexa Announces Partnership with Syngene To Manufacture MTX240 GMP Clinical Trial Supplies • GlobeNewswire Inc. • 04/02/2026 12:30:00 PM
Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 03/31/2026 04:15:17 AM
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/27/2026 09:00:06 PM
Preliminary Results for the Year Ended 31 December 2025 • GlobeNewswire Inc. • 03/27/2026 09:00:00 PM
Biodexa Launches Global Early Access Program for eRapa for FAP Patients Through Strategic Partnership with Tanner Pharma Group • GlobeNewswire Inc. • 03/23/2026 12:30:00 PM
Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/20/2026 09:19:51 PM
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/18/2026 09:11:41 PM
ADR Ratio Change • GlobeNewswire Inc. • 03/18/2026 09:00:00 PM
Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 01:30:20 PM
Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 01:30:18 PM
Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 01:30:15 PM
Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 01:30:12 PM

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Detailed Quote

Recent BDRX News

More BDRX News

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Recent BDRX News

Go Ad-Free